Medix's mission is to provide high quality health products and services that exceed customer expectations in areas like obesity, gastroenterology, and the central nervous system. Its vision is to achieve $100 million in sales by 2012 through sustained growth. Core values include effectiveness, quality, creativity, loyalty, passion, commitment, integration, and process efficiency. Medix has over 475 employees and 50 years of experience in Mexico. It offers a portfolio of products for gastroenterology and other medical areas. Medix is developing its business through partnerships, a customer relationship management system, exports, and a future pharmaceutical research center.

3. MISSION
To contribute to the market of health products and services that surpass the
expectations of our clients in the matter of quality and availability, all of it based on
strengthening the development of the therapeutic areas of obesity,
gastroenterology, central nervous system and metabolics,
complemented with other
areas or niches of market
that constitute a very attractive opportunity for the company.

4. VISION
To achieve sales of 100 million
Dollars by the year 2012, always looking for
sustained growth and proper retribution for the
workers and shareholders in the company.

5. VALUES
EFFECTIVENESS
Working well with commitment and with proper opportunity .
QUALITY
Surpass the expectations of our clients in terms or quality of products and services to
customers.
CREATIVITY
Improving permanently our processes and our portfolio of products and services.
LOYALTY
To develop and sustain a sense of affiliation and identity with the Medix® group
PASSION
Perform activities with perseverance end enthusiasm .
COMMITMENT
To assume responsibilities and comply them fully.
INTEGRATION
To achieve our objectives and to increase our productivity through team work.
PROCESS OPERATION
Companies growth based on proper and adequate integration and efficiency of all
processes .

7. medix has been evolving with strong
social commitment, and providing
our human, financial and
technological assets/resources
towards continuous improvement of
ourselves and our environment.
With over more than 475
collaborators, medix has been
involved in the quest of new horizons
that will allow us to provide broader,
better service to our customers in all
areas.

8. medix has over 50 years
of experience in the
Mexican market; this
experience gives medix a
highly competitive edge in
national and international
markets.
Our competitive edge is
d u e t o t h e q u a l i t y,
efficiency and safety we
offer to healthcare
practitioners and
consumers.

9. Medix Group

10. GRUPO MEDIX CHART 2007
Real State
Companies
Leasing Printing
Companies Company.
GRUPO
New center
for
MEDIX Financial
development and loan
and Companies
research.
Short Term Productos
Hospital Medix S.A.
Center de C.V.

11. Organizational Health Division medix
Chart Group
Chairrman of the Board
Grupo Medix
Julio Hoth y Alatriste
Corporate Services Grupo Medix Assitance Services
Audiit Ernesto Valllet Haces Renato Novoa
Legal Director CEO Health Companies
Mario Lazcano Torres Carlos Lopez Patan
Operations Director Technical Director CFO New Products and Commercial
Enrique Reyna Carmen Orta Jorge Santiago planeation. Director Corporate Services
Roberto Goti Carlos Bujosevich Victor ESPINOZA

12. OFFICIAL AUTHORIZATIONS
Pharmaceutical Industry Database
2. Sanitary License No. 09 004 02 0032
3. Federal Environmental License (LAU). (ren.10/Jun.2004)
4. Environmental License Mexico City
5. Certificate of Good Production Practices for raw material and dental products
6. Certification of Good Manufacturing Practices
7. Authorized Production Lines.
7.1 Hormone Production. Solid oral presentations: Capsules, pills, tablets
7.2 Production of Herbal Products. Solid, liquid and semisolid oral presentations
7.3 Goods and services. Dietary Supplements. Separate areas: Cleaning, Perfume
and Beauty, Warehouse for raw material
7.4 Dental Product production.
7.5 Healing/First-Aid products.
8. Authorized Allopathic Pharmaceuticals
8.1 Oral Solids: Capsules, pills, tablets
8.2 Oral Liquids: Solutions, emulsions, syrups
8.3 Semisolids: Suppositories: creams, gels, ovules, ointments
9.- Invima Certified Plant .
10.- Conacyt Award Achievement.

13. Product Engineering
actualizar por
planta.
Critical Systems Projects
CRITICAL SYSTEM
COMPRESSED AIR
Basic and Conceptual Engineering
Detail Engineering
Adquisition of Equipment
AIR CONDITIONING (HVAC)
Basic and Conceptual Engineering
PURIFIED WATER
Basic and Conceptual Engineering

14. PLANT ENGINEERING
Preventative Maintenance Program
MAINTENANCE PROGRAM
COMPLY WITH PREVENTIVE MAINTENANCE
Mechanical
Civil
HOURS OF MACHINERY NON-USE
Production Machinery in non-use for correctional practices
Preventative Maintenance

15. Outsourcing Services for Third Parties.
» Lemery Laboratories
» Serral Laboratories
» Innovare Laboratory
» New Beginnings
» Helm of Mexico
» Combe Lab.
» Hispanoamericana Lab.
» Servicio Empresarial Total
» Micrometrix Lab.
» Solvay

16. MONTHLY CAPACITY
UNITS USED
DESCRIPTION
.
LINER 170,000 44.5%
BLOWER 99,000 60.2%
INJECTOR 138,600 58.2%
BAND TABLE 82,500 49.2%
IMA BLISTERPACKAGING 206,250 48.4%
NATURAL FIT 19,800 50.2%
LIQUIDS 24,750 0.0%
CARTON PACKAGING 277,200 49.5%
ALTERNATIVE PACKAGING 14,850 50.5%
GRANULATES 7,600 78.9%
PILLS 775,500 32.4%
MICROSPHERES 1,683 53.8%
DUMOULIN BLENDER 1,980 34.1%
TABLETS 36,630,000 81.4%
ENCAPSULATES 4,125,000 84.5%
Levels of Production
CREAMS 56,000 73.1%
and installation capacity
HORMONALS 198,000 41.9%
DISPENSARY 25 92.9%
CAPSULES II 1,650,000 82.0%
MIXER 7,000 82.9%

17. Production Plant
Production Plant

18. Outside VIEW

19. Microbiology Department

20. Quality Control
and Quality Assurance Department

21. GLATT. Granulate Blender
T.K. FIELDER. Dry Granulate Machine

22. Sugar and Filmcoating Blenders

23. Blender Mix
V- Blender Mix

24. Liquid & Emulsion Reactor
Filmcoating & Microspheres
Procedure Machine

25. KILLIAN T200. Compressed Tablet Machine

26. SYNTHESIS 300. Compressed Tablet Machine

27. MG2. Capsule Fillingmachine
Semiautomatic Capsule Fillingmachine

28. IMA. Blisterpack Machine

29. Liquid Fillingmachine
Tube Fillingmachine (For creams)

30. Manual Packaging Area of finished Product

31. V2. Packaging Machine

32. INSIDE VIEW

33. Pharmaceutical Forms
Pharmaceutical Forms

34. medix
Capsules

35. Logistics Management. Warehouse

36. Makes the Diference

37. THE DIALICELS SYSTEM
THE DIALICELS SYSTEM
Slow and sustained therapeutical effect that allows for rapid
recovery.
Avoids the ups and downs in active concentrations
common in conventional fast-absorbing drugs.
Avoids fluctuation in the pharmacological response - allows
for easy dose-adjustments.
The bioavailability of drugs used with the Dialicels system
is comparable to administering a continuous I.V. drip.
Decrease in number of doses contributes to greater loyalty
and adherence to the treatment.
Increase in stability. Dialicels. Is the registered trademark
of medix for capsules that contain micro-
Decrease in AE’s vs. common drugs. spheres (pellets) that perform as
The Dialicels system does not modify intestinal peristalsis, microcells. These micro-spheres have a
dialyzer membrane that allows a
gastrointestinal enzymes, pH, food, flora, biliary secretion
sustained-slow release of drugs.
and does not show adverse interactions with other drugs.
Disguises original drug flavor.

38. Dialicels® Make-Up
Dialyzing Material
Nucleus
Medication

39. Advantages of Dialicels®
Increasing the bioavailability of orally administered medications
so as to be comparable with a continuous IV drip. The benefits
of bioavailability of the Dialicels® system can be osbserved in
the following areas:
1.- Digestive Apparatus
2.- Absorption
3.- Blood concentrations
4.- Tissues
5.- Medical Prescriptions
6.-Patient Comfort

40. Products Developed using the Dialicels® system
• Indometacine
• Dextrometorfane
• Fenproporex
• Ferrous Fumarate
• Ketoprofene
• Amfepramone
• Tramadol
• D-Norseudoefedrine, Triyodotironine, Diazepam, Atropine and Aloine
• Lorazepam
• Mazindol
• Melatonine

41. Product Categories

42. Major Rx Players into the industry
2%
1%
1%
4%
5%
5%
12%
70%
Source: INTE

43. At present medix has a commercial list of 45
products positioned mainly in this categories:
– Gastroenterology
– Others ( General Medicine).
We are also Developing new products for :
- Central Nervous system
- Metabolism

44. medix Portfolio by Segment
52%
14%
8%
4%
4%
3%
3%
3%
3%
2%
1%
1%
0.026%
0.05%
Source: PMM

47. GENERICS
GENERICS

48. EVOLUTION OF GENERICS IN MEXICO
Generics in niches with good demand; average 2-3 producers as competition.

50. Outsourcing Agreement
• Health Mart

51. Health Mart Partnership Objectives
• As a strategic partner for medix to manage the
commercialization process (current and New
products) in an effective, efficient and highly
profitable manner.
• To facilitate the medix strategic focus on processes
that deliver competitive advantages within the
Mexican Pharmaceutical Market.

52. Partnership Terms
• Health Mart fee’s of medix net sales
• Medical samples sold to Health Mart.
• Cost of discounts and/or promotional activities charged
to medix
• Marketing plans authorized by medix
• medix entitled to field monitoring and marketing plan
implementations
• Monthly review of KPI´s

53. Strategic Partnership medix-Health
• We have a sales force of 192 collaborators

54. Customer Relationship
Management

55. Call center www.medix.com.mx
CRM
The main objective of our loyalty program is to
establish direct links of relationship with
physicians to obtain valuable information; in this way, we may
understand their potential as clients,
directing and targeting to continue making our promotional efforts
more profitable.

56. OUR WEB PAGE

57. EXPORTS

58. medix Distribution network in 10
Latin American countries.

59. Our Immediate future
• Pharmaceutical Research Center.
*Under Development , Expected for 2008.

60. Our goal is the future!